CME Group is pleased to announce that in addition to continuing to accept complaints concerning market activity and self-reports of rule violations via telephone and email, we have added an electronic complaint link and self-report link available on the CME Group website at the following locations:
Complaint Link: http://www.cmegroup.com/market-regulation/file-complaint.html
Self-Report Link: http://www.cmegroup.com/market-regulation/self-report.html
To file a complaint or self-report an incident through the CME Group website, please go to the complaint or self-report link and fill in the required fields. Please include as much information as possible to assist Market Regulation in its review of the complaint or self-report. As with all complaints and self-reports of rule violations provided to the Market Regulation Department, the information obtained through the web-based links is confidential and will not be disclosed except as necessary to further an Exchange investigation or as required by law pursuant to the requirements of each Exchanges’ Rule 407 (“Investigation, Assignment for Hearing and Notice of Charges”).
If you have questions concerning the information in this Special Executive Report, please contact one of the following individuals in the Market Regulation Department:
Mary Hillstrom, Senior Investigator, 312.341.7632
Erin Coffey, Senior Rules & Regulatory Outreach Specialist, 312.341.3286
Robert Sniegowski, Senior Director, Rules & Regulatory Outreach, 312.341.5991
For media inquiries concerning this Special Executive Report, please contact CME Group Corporate Communications at 312.930.3434 or firstname.lastname@example.org.
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.